The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Targeting antioxidants for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Selective killing of cancer cells by a small molecule targeting the stress response to ROS
Raj, L., Ide, T., Gurkar, A. U., Foley, M., Schenone, M., Li, X., Tolliday, N. J., Golub, T. R., Carr, S. A., Shamji, A. F., et al. (2011) · Nature · doi:10.1038/nature10167 · Cited by 1,030
RetractedAdhikary, A., Mohanty, S., Lahiry, L., Hossain, D. M. S., Chakraborty, S., & Das, T. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.081 · Cited by 79
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 2×
“As mentioned previously, hypoxia is a hallmark characteristic of many cancers [58] and has been shown to increase ROS production [59].”
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 9×
“Under normal conditions NRF2 localizes in the cytoplasm, where it interacts with the actin-binding protein, Kelch-like ECH-associated protein 1 (KEAP1) [33,34].”
InfluentialModulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
NOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125
Reactive oxygen species in cell signaling
Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,927
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
Physiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Self-citationAssociation of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 2,526
Wallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377
Ichijo, H., Nishida, E., Irie, K., Dijke, P. T., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., & Gotoh, Y. (1997) · Science · doi:10.1126/science.275.5296.90 · Cited by 2,307
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Self-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Klein, E. A., Thompson, I. M., Tangen, C. M., Crowley, J. J., Lucia, M. S., Goodman, P. J., Minasian, L. M., Ford, L. G., Parnes, H. L., Gaziano, J. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1437 · Cited by 1,787
Blot, W. J., Li, J.-Y., Taylor, P. R., Guo, W., Dawsey, S., Wang, G.-Q., Yang, C. S., Zheng, S.-F., Gail, M., Li, G.-Y., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.18.1483 · Cited by 1,760
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742
Self-citationGriffith, O. W., & Meister, A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35980-5 · Cited by 1,683 · cited 1×
“of glutamylcysteine synthetase (g-GCS) [155].”
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
Kops, G. J. P. L., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W. A., Coffer, P. J., Huang, T.-T., Bos, J. L., Medema, R. H., & Burgering, B. M. T. (2002) · Nature · doi:10.1038/nature01036 · Cited by 1,580
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., & Yamamoto, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16023 · Cited by 1,460
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395 · cited 5×
“Hence, cancer cells have the ability to develop resistance to therapeutics that exogenously raise ROS by increasing their antioxidant mechanisms, such as activation and stabilization of the antioxidant master regulator NRF2 [8,11,154] or other ROS scavengers [13,14].”
InfluentialRac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
Selective Modification of Glutathione Metabolism
Meister, A. (1983) · Science · doi:10.1126/science.6836290 · Cited by 1,267 · cited 1×
“The eight known GRXs function similar to PRXs and eliminate H2O2 through the H2O2-mediated oxidization of glutathione (GSH), the most abundant antioxidant in the cell [32].”
Induction of Apoptosis by Cancer Chemotherapy
Kaufmann, S. H., & Earnshaw, W. C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4838 · Cited by 1,266
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69600 · Cited by 1,262
Reactive oxygen species in cancer cells: Live by the sword, die by the sword
Schumacker, P. T. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.015 · Cited by 1,242
Thiol chemistry and specificity in redox signaling
Winterbourn, C. C., & Hampton, M. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.004 · Cited by 1,226
The sites and topology of mitochondrial superoxide production
Brand, M. D. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.003 · Cited by 1,217
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., & Ichijo, H. (2001) · EMBO reports · doi:10.1093/embo-reports/kve046 · Cited by 1,210
Finkel, T. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80147-6 · Cited by 1,170
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.009 · Cited by 1,080
Molecular Mechanisms Activating the Nrf2-Keap1 Pathway of Antioxidant Gene Regulation
Kobayashi, M., & Yamamoto, M. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.385 · Cited by 1,076
Reversible Inactivation of the Tumor Suppressor PTEN by H2O2
Lee, S.-R., Yang, K.-S., Kwon, J., Lee, C., Jeong, W., & Rhee, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111899200 · Cited by 1,057
Chiang, A. C., & Massagué, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0805239 · Cited by 1,054
Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo
Meng, T.-C., Fukada, T., & Tonks, N. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00445-8 · Cited by 1,040
Complex iii releases superoxide to both sides of the inner mitochondrial membrane
Muller, F. L., Liu, Y., & Van Remmen, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407715200 · Cited by 1,036
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031
Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes
Hamanaka, R. B., & Chandel, N. S. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.002 · Cited by 1,011
Self-citationLee, S.-R., Kwon, K.-S., Kim, S.-R., & Rhee, S. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15366 · Cited by 969
Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate
Salmeen, A., Andersen, J. N., Myers, M. P., Meng, T.-C., Hinks, J. A., Tonks, N. K., & Barford, D. (2003) · Nature · doi:10.1038/nature01680 · Cited by 951
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
Hayes, J. D., & McMahon, M. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.12.008 · Cited by 869
Antioxidants Accelerate Lung Cancer Progression in Mice
Sayin, V. I., Ibrahim, M. X., Larsson, E., Nilsson, J. A., Lindahl, P., & Bergo, M. O. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007653 · Cited by 867
Kobayashi, M., & Yamamoto, M. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.007 · Cited by 856
Superoxide dismutase as a target for the selective killing of cancer cells
Huang, P., Feng, L., Oldham, E. A., Keating, M. J., & Plunkett, W. (2000) · Nature · doi:10.1038/35030140 · Cited by 842
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Wang, X.-J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn095 · Cited by 839
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
Wang, J.-B., Erickson, J. W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K. F., Ambrosio, A. L. B., Dias, S. M. G., Dang, C. V., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.009 · Cited by 821
Redox Regulation of Forkhead Proteins Through a p66shc -Dependent Signaling Pathway
Nemoto, S., & Finkel, T. (2002) · Science · doi:10.1126/science.1069004 · Cited by 818
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Wertz, I. E., Kusam, S., Lam, C., Okamoto, T., Sandoval, W., Anderson, D. J., Helgason, E., Ernst, J. A., Eby, M., Liu, J., et al. (2011) · Nature · doi:10.1038/nature09779 · Cited by 794
Nogueira, V., Park, Y., Chen, C.-C., Xu, P.-Z., Chen, M.-L., Tonic, I., Unterman, T., & Hay, N. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.003 · Cited by 780
Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness
Conklin, K. A. (2004) · Integrative Cancer Therapies · doi:10.1177/1534735404270335 · Cited by 752
Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype
Kumar, B., Koul, S., Khandrika, L., Meacham, R. B., & Koul, H. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5259 · Cited by 736
Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728
Metabolic targets for cancer therapy
Galluzzi, L., Kepp, O., Heiden, M. G. V., & Kroemer, G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4145 · Cited by 711
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673
Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy
Ushio-Fukai, M., & Nakamura, Y. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.044 · Cited by 651
Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., & Zhang, D. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.029 · Cited by 638
Kwon, J., Lee, S.-R., Yang, K.-S., Ahn, Y., Kim, Y. J., Stadtman, E. R., & Rhee, S. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407396101 · Cited by 631
Timmerman, L. A., Holton, T., Yuneva, M., Louie, R. J., Padró, M., Daemen, A., Hu, M., Chan, D. A., Ethier, S. P., van ‘t Veer, L. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.020 · Cited by 573 · cited 1×
“A recent study also identified xCT as a therapeutic target in a xenograft model of triple-negative breast cancer [164].”
Khaw, K.-T., Bingham, S., Welch, A., Luben, R., Wareham, N., Oakes, S., & Day, N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04128-3 · Cited by 573
Bell, E. L., Klimova, T. A., Eisenbart, J., Moraes, C. T., Murphy, M. P., Budinger, G. R. S., & Chandel, N. S. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200609074 · Cited by 568
Self-citationMitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging?
Bandy, B., & Davison, A. J. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90152-9 · Cited by 550
Sasaki, H., Sato, H., Kuriyama-Matsumura, K., Sato, K., Maebara, K., Wang, H., Tamba, M., Itoh, K., Yamamoto, M., & Bannai, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208704200 · Cited by 542
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
Hayes, J. D., McMahon, M., Chowdhry, S., & Dinkova-Kostova, A. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3221 · Cited by 539
Reactive oxygen species in oncogenic transformation
Behrend, L., Henderson, G., & Zwacka, R. M. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311441 · Cited by 531
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Lu, J., Chew, E.-H., & Holmgren, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701549104 · Cited by 526
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
Gao, P., Zhang, H., Dinavahi, R., Li, F., Xiang, Y., Raman, V., Bhujwalla, Z. M., Felsher, D. W., Cheng, L., Pevsner, J., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.004 · Cited by 523
Gaziano, J. M., Glynn, R. J., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Sesso, H. D., & Buring, J. E. (2009) · JAMA · doi:10.1001/jama.2008.862 · Cited by 518
Xia, C., Meng, Q., Liu, L.-Z., Rojanasakul, Y., Wang, X.-R., & Jiang, B.-H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0783 · Cited by 507
Inhibition of Mitochondrial Respiration
Pelicano, H., Feng, L., Zhou, Y., Carew, J. S., Hileman, E. O., Plunkett, W., Keating, M. J., & Huang, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301546200 · Cited by 495
Lee, I.-M., Cook, N. R., Manson, J. E., Buring, J. E., & Hennekens, C. H. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2102 · Cited by 467
Conklin, K. A. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3701_1 · Cited by 464
Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
Wondrak, G. T. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2541 · Cited by 462
Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival
Thornton, T. M., & Rincon, M. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.44 · Cited by 443
Mitochondrial complex III regulates hypoxic activation of HIF
Klimova, T., & Chandel, N. S. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402307 · Cited by 433
Self-citationTranslocation of SAPK/JNK to Mitochondria and Interaction with Bcl-xL in Response to DNA Damage
Kharbanda, S., Saxena, S., Yoshida, K., Pandey, P., Kaneki, M., Wang, Q., Cheng, K., Chen, Y.-N., Campbell, A., Sudha, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.322 · Cited by 429
Marzano, C., Gandin, V., Folda, A., Scutari, G., Bindoli, A., & Rigobello, M. P. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.021 · Cited by 415
p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis
Dolado, I., Swat, A., Ajenjo, N., De Vita, G., Cuadrado, A., & Nebreda, A. R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.013 · Cited by 404
Reactive oxygen species in tumor metastasis
Nishikawa, M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.031 · Cited by 398
Role for mitochondrial oxidants as regulators of cellular metabolism
Nemoto, S., Takeda, K., Yu, Z.-X., Ferrans, V. J., & Finkel, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7311-7318.2000 · Cited by 393
Signal Transduction by Mitochondrial Oxidants
Finkel, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.271999 · Cited by 390
Protective effect of green tea against prostate cancer: A case‐control study in southeast China
Jian, L., Xie, L. P., Lee, A. H., & Binns, C. W. (2004) · International Journal of Cancer · doi:10.1002/ijc.11550 · Cited by 369
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
Kim, Y. R., Oh, J. E., Kim, M. S., Kang, M. R., Park, S. W., Han, J. Y., Eom, H. S., Yoo, N. J., & Lee, S. H. (2010) · The Journal of Pathology · doi:10.1002/path.2653 · Cited by 358
Elesclomol induces cancer cell apoptosis through oxidative stress
Kirshner, J. R., He, S., Balasubramanyam, V., Kepros, J., Yang, C.-Y., Zhang, M., Du, Z., Barsoum, J., & Bertin, J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0298 · Cited by 353
Berndt, C., Lillig, C. H., & Holmgren, A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01162.2006 · Cited by 352
Structural biochemistry and activation of matrix metalloproteases
Kleiner, D. E., & Stetler-Stevenson, W. G. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90040-w · Cited by 342
Qiao, Y.-L., Dawsey, S. M., Kamangar, F., Fan, J.-H., Abnet, C. C., Sun, X.-D., Johnson, L. L., Gail, M. H., Dong, Z.-W., Yu, B., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp037 · Cited by 324
Mitochondrial Manganese-Superoxide Dismutase Expression in Ovarian Cancer
Hu, Y., Rosen, D. G., Zhou, Y., Feng, L., Yang, G., Liu, J., & Huang, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503296200 · Cited by 279
Reactive oxygen species-dependent signaling regulates cancer
Weinberg, F., & Chandel, N. S. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0099-y · Cited by 275
Self-citationRedox signaling across cell membranes
Fisher, A. B. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2378 · Cited by 269
The pathways to tumor suppression via route p38
Han, J., & Sun, P. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.06.007 · Cited by 267
Rahman, I., Gilmour, P. S., Jimenez, L. A., & MacNee, W. (2002) · Oxygen/Nitrogen Radicals: Cell Injury and Disease · doi:10.1007/978-1-4615-1087-1_28 · Cited by 260
Juarez, J. C., Manuia, M., Burnett, M. E., Betancourt, O., Boivin, B., Shaw, D. E., Tonks, N. K., Mazar, A. P., & Doñate, F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709451105 · Cited by 257
Satoh, H., Moriguchi, T., Takai, J., Ebina, M., & Yamamoto, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4499 · Cited by 251
(2003) · PubMed · Cited by 250
The emerging role of reactive oxygen species in cancer therapy
Renschler, M. F. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.031 · Cited by 237
Rahman, I., Gilmour, P. S., Jimenez, L. A., & MacNee, W. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015905010086 · Cited by 236
Chou, W.-C., Jie, C., Kenedy, A. A., Jones, R. J., Trush, M. A., & Dang, C. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306687101 · Cited by 234
Phosphorylation and Inactivation of Myeloid Cell Leukemia 1 by JNK in Response to Oxidative Stress
Inoshita, S., Takeda, K., Hatai, T., Terada, Y., Sano, M., Hata, J., Umezawa, A., & Ichijo, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207951200 · Cited by 233
Kotamraju, S., Chitambar, C. R., Kalivendi, S. V., Joseph, J., & Kalyanaraman, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111604200 · Cited by 233
Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress
Shaw, A. T., Winslow, M. M., Magendantz, M., Ouyang, C., Dowdle, J., Subramanian, A., Lewis, T. A., Maglathin, R. L., Tolliday, N., & Jacks, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105941108 · Cited by 230
Profiling protein thiol oxidation in tumor cells using sulfenic acid-specific antibodies
Seo, Y. H., & Carroll, K. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903015106 · Cited by 230
Mechanisms of ROS modulated cell survival during carcinogenesis
Clerkin, J. S., Naughton, R., Quiney, C., & Cotter, T. G. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.029 · Cited by 219
Savitsky, P. A., & Finkel, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201589200 · Cited by 218
Nelson, S. K., Bose, S. K., Grunwald, G. K., Myhill, P., & McCord, J. M. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.043 · Cited by 215
Targeting SOD1 reduces experimental non–small-cell lung cancer
Glasauer, A., Sena, L. A., Diebold, L. P., Mazar, A. P., & Chandel, N. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71714 · Cited by 212
Self-citationReactive oxygen species are downstream products of TRAF-mediated signal transduction
Chandel, N. S., Schumacker, P. T., & Arch, R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103074200 · Cited by 203
Self-citationEffective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism
Trachootham, D., Zhang, H., Zhang, W., Feng, L., Du, M., Zhou, Y., Chen, Z., Pelicano, H., Plunkett, W., Wierda, W. G., et al. (2008) · Blood · doi:10.1182/blood-2008-04-149815 · Cited by 203
Oxidative stress and apoptosis: a new treatment paradigm in cancer
Engel, R. (2006) · Frontiers in Bioscience · doi:10.2741/1798 · Cited by 202
Maeda, H., Hori, S., Ohizumi, H., Segawa, T., Kakehi, Y., Ogawa, O., & Kakizuka, A. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401389 · Cited by 183
Kamata, H., Manabe, T., Oka, S.-I., Kamata, K., & Hirata, H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02712-6 · Cited by 179
Antioxidant Supplementation Increases the Risk of Skin Cancers in Women but Not in Men
Hercberg, S., Ezzedine, K., Guinot, C., Preziosi, P., Galan, P., Bertrais, S., Estaquio, C., Briançon, S., Favier, A., Latreille, J., et al. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.9.2098 · Cited by 173
Sweeney, C., Liu, G., Yiannoutsos, C., Kolesar, J., Horvath, D., Staab, M. J., Fife, K., Armstrong, V., Treston, A., Sidor, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0440 · Cited by 172
Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines
Davison, K., Côté, S., Mader, S., & Miller, W. H. (2003) · Leukemia · doi:10.1038/sj.leu.2402876 · Cited by 165
Mehta, M. P., Shapiro, W. R., Phan, S. C., Gervais, R., Carrie, C., Chabot, P., Patchell, R. A., Glantz, M. J., Recht, L., Langer, C., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.05.068 · Cited by 164
Phase I Study of Continuous-Infusion L-S,R-Buthionine Sulfoximine With Intravenous Melphalan
Bailey, H. H., Ripple, G., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Feierabend, C., Mahvi, D., Schink, J., Pomplun, M., Mulcahy, R. T., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1789 · Cited by 164
Motexafin gadolinium: A novel redox active drug for cancer therapy
Magda, D., & Miller, R. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.002 · Cited by 162
Isoform-specific regulation of Akt by PDGF-induced reactive oxygen species
Wani, R., Qian, J. X., Yin, L.-M., Bechtold, E., King, S. B., Poole, L. B., Paek, E., Tsang, A. W., & Furdui, C. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011665108 · Cited by 162
The cunning little vixen: Foxo and the cycle of life and death
Hedrick, S. M. (2009) · Nature Immunology · doi:10.1038/ni.1784 · Cited by 157
Somwar, R., Erdjument‐Bromage, H., Larsson, E., Shum, D., Lockwood, W. W., Yang, G., Sander, C., Ouerfelli, O., Tempst, P., Djaballah, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113554108 · Cited by 156
Cell cycle regulation by p38 MAP kinases
Ambrosino, C., & Nebreda, Á. R. (2001) · Biology of the Cell · doi:10.1016/s0248-4900(01)01124-8 · Cited by 151
Butein induces G2/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation
Moon, D.-O., Kim, M.-O., Choi, Y. H., Hyun, J. W., Chang, W. Y., & Kim, G.-Y. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.07.002 · Cited by 151
Kemble, D. J., & Sun, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806117106 · Cited by 149
Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors
Vooijs, M., Gort, E. H., Groot, A. J., van der Wall, E., & van Diest, P. J. (2008) · Current Molecular Medicine · doi:10.2174/156652408783565568 · Cited by 146
Saydam, N., Kirb, A., Demir, Ö., Hazan, E., Oto, O., Saydam, O., & Güner, G. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00245-0 · Cited by 141
Young, T. W., Mei, F. C., Yang, G. S., Thompson-Lanza, J. A., Liu, J., & Cheng, X. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0222 · Cited by 136
Guan, J., Lo, M., Dockery, P., Mahon, S., Karp, C. M., Buckley, A. R., Lam, S., Gout, P. W., & Wang, Y.-Z. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0894-4 · Cited by 134
Wine and resveratrol: mechanisms of cancer prevention?
Bianchini, F., & Vainio, H. (2003) · European Journal of Cancer Prevention · doi:10.1097/00008469-200310000-00011 · Cited by 134
Mitochondrial regulation of oxygen sensing
Bell, E. L., Emerling, B. M., & Chandel, N. S. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.06.005 · Cited by 130
Self-citationJames, J. S., Murry, D. J., Treston, A. M., Storniolo, A. M., Sledge, G. W., Sidor, C. F., & Miller, K. D. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-9008-5 · Cited by 128
Beneficial effects of tea and its polyphenols against prostate cancer
Siddiqui, I. A., Adhami, V. M., Saleem, M., & Mukhtar, H. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500113 · Cited by 126
Antioxidant inhibitors for cancer therapy
Kong, Q., & Lillehei, K. O. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90036-6 · Cited by 124
Lo, M., Ling, V., Low, C., Wang, Y. Z., & Gout, P. W. (2010) · Current Oncology · doi:10.3747/co.v17i3.485 · Cited by 120
Expression and Activity of NOX5 in the Circulating Malignant B Cells of Hairy Cell Leukemia
Kamiguti, A. S., Serrander, L., Lin, K., Harris, R. J., Cawley, J. C., Allsup, D. J., Slupsky, J. R., Krause, K., & Zuzel, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8424 · Cited by 118
Kim, H.-S., Bowen, P. E., Chen, L., Duncan, C., Ghosh, L., Sharifi, R., & Christov, K. T. (2003) · Nutrition and Cancer · doi:10.1207/s15327914nc4701_5 · Cited by 114
Redox Regulation of MAP Kinase Phosphatase 3
Seth, D., & Rudolph, J. (2006) · Biochemistry · doi:10.1021/bi060157p · Cited by 111
EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2
Binker, M. G., Binker-cosen, A. A., Richards, D., Oliver, B., & Cosen-Binker, L. I. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.080 · Cited by 110
Wu, X., Zhu, Y. T., Yan, H., Liu, B., Li, Y., Zhou, Q., & Xu, K. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-269 · Cited by 108
Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase
Reinert, R. B., Oberle, L. M., Wek, S. A., Bunpo, P., Wang, X. P., Mileva, I., Goodwin, L. O., Aldrich, C. J., Durden, D. L., McNurlan, M. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604511200 · Cited by 107
Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma
Ma, Q., Cavallin, L. E., Yan, B., Zhu, S., Duran, E. M., Wang, H., Hale, L. P., Dong, C., Cesarman, E., Mesri, E. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812688106 · Cited by 105
Chemotherapy: induction of stress responses
Tiligada, E. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01272 · Cited by 103
Patel, B. P., Rawal, U. M., Dave, T. K., Rawal, R., Shukla, S. N., Shah, P. M., & Patel, P. S. (2007) · Integrative Cancer Therapies · doi:10.1177/1534735407309760 · Cited by 99
Luca, A. D., Sanna, F., Sallese, M., Ruggiero, C., Grossi, M., Sacchetta, P., Rossi, C., Laurenzi, V. D., Ilio, C. D., & Favaloro, B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010171107 · Cited by 99
Nitsche, C. J., Edderkaoui, M., Moore, R. M., Eibl, G., Kasahara, N., Treger, J. M., Grippo, P. J., Mayerle, J. V., Lerch, M. M., & Gukovskaya, A. S. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.026 · Cited by 98
Does Scavenging of Mitochondrial Superoxide Attenuate Cancer Prosurvival Signaling Pathways?
Nazarewicz, R. R., Dikalova, A., Bikineyeva, A. T., Ivanov, S. V., Kirilyuk, I. A., Григорьев, И. А., & Dikalov, S. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5185 · Cited by 97
Seo, J. M., Park, S., & Kim, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.317131 · Cited by 96
Teoh-Fitzgerald, M. L. T., Fitzgerald, M. P., Zhong, W., Askeland, R. W., & Domann, F. E. (2013) · Oncogene · doi:10.1038/onc.2012.582 · Cited by 95
Ho, B., Wu, Y., Chang, K., & Pan, T. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.869 · Cited by 95
Policastro, L., Molinari, B. L., Larcher, F., Blanco, P., Podhajcer, O. L., Costa, C. S., Rojas, P. A., & Durán, H. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20001 · Cited by 93
Cell migration and invasion in human disease: the Tks adaptor proteins
Courtneidge, S. A. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110685 · Cited by 92
Probing p53 biological functions through the use of genetically engineered mouse models
Attardi, L. D., & Donehower, L. A. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.08.022 · Cited by 90
Sobhakumari, A., Love-Homan, L., Fletcher, E. V. M., Martin, S. M., Parsons, A. D., Spitz, D. R., Knudson, C. M., & Simons, A. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048175 · Cited by 80
Doñate, F., Juárez, J., Burnett, M. E., Manuia, M., Guan, X., Shaw, D. E., Smith, E. L., Timuçin, A. C., Braunstein, M. J., Batuman, O., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604226 · Cited by 78
Vitamin Intake and Liver Cancer Risk: A Report From Two Cohort Studies in China
Zhang, W., Shu, X., Li, H., Yang, G., Cai, H., Ji, B.-T., Gao, J., Gao, Y., Zheng, W., & Xiang, Y. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs277 · Cited by 78
Kumar, K. U., Yehiely, F., Efimova, E. V., Harasty, H., Hesabi, B., Shchors, K., Einat, P., Rozen, A., Berent, E., & Deiss, L. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206077 · Cited by 77
Liu, J., Du, J., Zhang, Y., Sun, W., Smith, B. J., Oberley, L. W., & Cullen, J. J. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.105 · Cited by 67
ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells
Chetram, M. A., Don-Salu-Hewage, A. S., & Hinton, C. V. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.074 · Cited by 64
The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies
Lee, K., Briehl, M. M., Mazar, A. P., Batinic̈‐Haberle, I., Reboucas, J. S., Glinsmann‐Gibson, B., Rimsza, L. M., & Tome, M. E. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.003 · Cited by 59
Phase I Trial of Imexon in Patients With Advanced Malignancy
Dragovich, T., Gordon, M. S., Mendelson, D. S., Wong, L., Modiano, M., Chow, H. ‐. S., Samulitis, B. K., O'Day, S. J., Grenier, K., Hersh, E. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9672 · Cited by 56
Zhang, Q., Ma, Y., Cheng, Y.-F., Li, W., Zhang, Z., & Chen, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.005 · Cited by 49
Chiu, J., Tactacan, C. M., Tan, S., Lin, R. C. Y., Wouters, M. A., & Dawes, I. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172973 · Cited by 38
Sceneay, J., Liu, M. C. P., Chen, A., Wong, C. S. F., Bowtell, D. D. L., & Möller, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066388 · Cited by 36
Lenehan, P. F., Gutiérrez, P. L., Wagner, J. L., Milak, N., Fisher, G. R., & Ross, D. D. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050250 · Cited by 35
Changes in intracellular redox status influence multidrug resistance in gastric adenocarcinoma cells
De-jun, T., Jin, W., WU, C.-S., SI, H.-W., Cao, X., GUO, A.-J., & Chang, J. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.591 · Cited by 34
Phase-ii study of pomegranate juice for men with prostate cancer and increasing psa
Pantuck, A. J., Zomorodian, N., & Belldegrun, A. S. (2006) · Current Urology Reports · doi:10.1007/s11934-006-0047-4 · Cited by 32
Qin, Y., Pan, X., Tang, T., Zhou, L., & Gong, X. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.07.004 · Cited by 22
Plasma ascorbic acid and risk of heart disease and cancer
Burr, M., Appleby, P. N., Key, T. J., & Thorogood, M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05207-7 · Cited by 11
Cited by
Oxidative Stress: Harms and Benefits for Human Health
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837
Sharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., Rajkovic, J., Tsouh Fokou, P. V., Azzini, E., Peluso, I., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00694 · Cited by 1,971
“Cancer initiation and promotion are associated with chromosomal defects and activation of oncogenes by free radicals (Glasauer and Chandel, 2014).”
BackgroundMetabolic pathways promoting cancer cell survival and growth
Boroughs, L. K., & DeBerardinis, R. J. (2015) · Nature Cell Biology · doi:10.1038/ncb3124 · Cited by 1,462
Oxidative stress inhibits distant metastasis by human melanoma cells
Piskounova, E., Agathocleous, M., Murphy, M. M., Hu, Z., Huddlestun, S. E., Zhao, Z., Leitch, A. M., Johnson, T. M., DeBerardinis, R. J., & Morrison, S. J. (2015) · Nature · doi:10.1038/nature15726 · Cited by 1,269
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
Metadata
- Authors
- Glasauer, A., & Chandel, N. S.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 92
- Issue
- 1
- Pages
- 90-101
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2077168519
- Cited by
- 499
- References
- 186
- FWCI
- 14.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.